| Literature DB >> 34739227 |
Eleanor Porges1,2,3,4, Dominic Jenner5, Adam W Taylor5,6, James S P Harrison4,7, Antonio De Grazia1,3, Alethia R Hailes1,2,3,4, Kimberley M Wright5, Adam O Whelan5, Isobel H Norville5, Joann L Prior5, Sumeet Mahajan4,7, Caroline A Rowland5, Tracey A Newman3,4, Nicholas D Evans1,2,4.
Abstract
Melioidosis caused by the facultative intracellular pathogen Burkholderia pseudomallei is difficult to treat due to poor intracellular bioavailability of antibiotics and antibiotic resistance. In the absence of novel compounds, polymersome (PM) encapsulation may increase the efficacy of existing antibiotics and reduce antibiotic resistance by promoting targeted, infection-specific intracellular uptake. In this study, we developed PMs composed of widely available poly(ethylene oxide)-polycaprolactone block copolymers and demonstrated their delivery to intracellular B. thailandensis infection using multispectral imaging flow cytometry (IFC) and coherent anti-Stokes Raman scattering microscopy. Antibiotics were tightly sequestered in PMs and did not inhibit the growth of free-living B. thailandensis. However, on uptake of antibiotic-loaded PMs by infected macrophages, IFC demonstrated PM colocalization with intracellular B. thailandensis and a significant inhibition of their growth. We conclude that PMs are a viable approach for the targeted antibiotic treatment of persistent intracellular Burkholderia infection.Entities:
Keywords: CARS imaging; Raman spectroscopy; antibiotics; imaging flow cytometry; intracellular bacteria; nanoparticles; polymersomes
Mesh:
Substances:
Year: 2021 PMID: 34739227 PMCID: PMC7612142 DOI: 10.1021/acsnano.1c05309
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881